New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 7, 2012
07:48 EDTCSCCSC price target raised to $39 from $34 at Stifel Nicolaus
Stifel Nicolaus increased its target on CSC after the company reported higher than expected EPS. The firm raised its FY13 EPS estimate to $2.50, the top of the company's guidance. The firm maintains a Buy rating.
News For CSC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 20, 2015
10:03 EDTCSCCSC awarded follow-on healthcare contract worth up to $90M
CSC announced that its company, DynPort Vaccine Company, received a follow-on contract to continue supporting the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Valued at up to $90M, the award is a 10-year Indefinite Delivery/Indefinite Quantity contract to support and conduct Phase 1 clinical trials of infectious disease therapeutics.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use